Elise Wang
Directeur/Membre du Conseil chez Jaguar Gene Therapy LLC
Profil
Elise Wang is a Partner and Head of Private Equity Capital Markets on the Public Structured Finance team and joined the Firm in 2010.
Ms. Wang provides extensive research and analysis on individual companies operating in the healthcare industry in both the US and Europe.
Ms. Wang is a board member of Jaguar Gene Therapy.
Prior to Deerfield, Ms. Wang was a Senior Research Analyst and Managing Director covering the biotechnology sector at PaineWebber and Citigroup.
She began her career in healthcare as a venture capitalist and banker at PaineWebber and was an officer of PaineWebber Development Corporation, which managed nearly $1 billion in assets representing three PaineWebber funds and several research and development limited partnerships (RDLPs) invested in biotechnology and high technology companies.
Ms. Wang holds an A.B.
in Engineering Sciences with a specialty in Biomechanics from Harvard University and an M.B.A.
from Harvard Business School.
Postes actifs de Elise Wang
| Sociétés | Poste | Début |
|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 01/07/2020 |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 01/03/2010 |
Anciens postes connus de Elise Wang
| Sociétés | Poste | Fin |
|---|---|---|
| HILLEVAX, INC. | Directeur/Membre du Conseil | - |
Formation de Elise Wang
| Harvard Business School | Masters Business Admin |
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HILLEVAX, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Health Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
